Baxdela ™ (delafloxacin) for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Baxdela ™ (delafloxacin) is a fluoroquinolone antibiotic drug indicated for the treatment of adults with acute bacterial skin and skin structure infections (ABSSSI). The drug was discovered and developed by Melinta Therapeutics in partnership with Lig…
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news